Dr. Yuguang Chris Li, Assistant Professor of Chemistry at University at Buffalo, founded PlasmaChem Solutions to commercialize a novel plasma-based method to more efficiently convert atmospheric nitrogen and water into ammonia.
read moreDr. Andrew Talal, a University at Buffalo Professor of Medicine and leading liver disease expert, first participated in I-Corps in 2020 to evaluate the market fit of a facilitated telemedicine approach for hepatitis C (HCV) treatment in opioid treatment programs.
read moreThis June, an I-Corps cohort of oncology researchers – each working on a cutting-edge solution to improve care and outcomes for cancer patients – took to Chicago for the American Society for Clinical Oncology (ASCO) Annual Meeting to interview clinicians about their biggest problems.
read moreQAS.AI, an I-Corps alumni startup from Buffalo, is at the forefront of developing AI-powered software designed to detect complications during brain surgery—such as impaired blood flow—and predict the success of chosen treatments in real time.
read moreAbceutics, an I-Corps alumni company based in Buffalo NY, was acquired by Merck, a global leader in biopharmaceuticals, for a potential consideration of up to $208 million.
read moreThe National Science Foundation has awarded Cornell University a $15 million, five-year grant to lead the newest Innovation Corps Hub, I-Corps: Interior Northeast Region.
read more





